ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Eight Firms Join AACR As Sustaining Members

April 25, 1997

NCI Cancer Prevention Fellowship Program

April 28, 2000

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007

In Brief: House Subcommittee Adds 15-17% to NIH 1987 Budget; NCI to Fund Lombardi, KY Centers

July 4, 1986

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

ORI Progress On Fisher Case Questioned; Panel Not Formed

March 3, 1995